Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Weber-Mzell, D; Zaupa, P; Petnehazy, T; Kobayashi, H; Schimpl, G; Feierl, G; Kotanko, P; Höllwarth, M.
The role of nuclear factor-kappa B in bacterial translocation in cholestatic rats.
Pediatr Surg Int. 2006; 22(1):43-49 Doi: 10.1007/s00383-005-1599-y
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Höllwarth Michael
Sperl Daniela Ingrid
Co-Autor*innen der Med Uni Graz
Feierl Gebhard
Zaupa Paola
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Xanthinoxidase (XO) derived radical species are involved in bacterial translocation (BT) in cholestatic rats. The mechanism by which XO influences remains unclear. It has been shown recently that nuclear factor-kappa B (NF-kappaB), a ubiquitous transcription factor, can be activated by oxidative stress and thereby promote the process of BT. We investigated the effects of NF-kappaB inactivation on the incidence of BT in cholestatic rats. Sprague-Dawley rats were randomly assigned to one of eight groups: groups 1-4 were sham laparotomized rats either untreated (S1) or treated for 5 days with thalidomide (S2), curcumin (S3), or Inchin-ko (ICK; S4); groups 5-8 underwent common bile duct ligation (CBDL) for 5 days and were either untreated (C1) or treated with thalidomide (C2), curcumin (C3), or ICK (C4). After 5 days bacteriological cultures were performed from portal blood and V. cava, from the central mesenteric lymph node complex (MLN), spleen, and liver. The intensity of the activated NF-kappaB-subunit p65/p50 in the ileum mucosa was estimated by light microscopy and a scoring system from 1 to 20. Malondialdehyde (MDA) and myeloperoxidase activity (MPO) in the ileum were evaluated and expressed as U/g dry weight. Thalidomide and ICK reduced in CBDL-rats significantly the BT rate (63% vs. 18%, 63% vs. 30%, P<0.01). Enzyme estimations (MDA, MPO, and GSH) in sham operated animals showed no significant changes in the untreated groups compared with the treated groups. CBDL-rats pre-treatment with all three compounds caused a significant increase of MDA levels if groups were compared with the untreated C1-group (C1 31.6+/-7.7, C2 54.5+/-12.2, C3 53.3+/-11.2, and C4 47.2+/-9.4). GSH was reduced after the pre-treatment by all compounds but only significantly after curcumin pre-treatment (C1 vs. C3: 13.9+/-1.8 vs. 7.1+/-1.8; P<0.05). MPO estimations were significantly higher in the untreated C1-group if compared with groups C2, C3, and C4 (C1 1036.4+/-340.9, C2 709.9+/-125.9, C3 545.2+/-136.6, and C4 556.7+/-247.4; P<0.05). Thalidomide inhibited significantly the activation of NF-kappaB (C2 vs. C1: 6.0+/-4.5 vs. 12.7+/-5.3; P<0.01). Likewise, Curcumin and ICK suppressed NF-kappaB activation, but this did not reach significance in this experiment. NF-kappaB is involved in the process of BT in cholestatic rats and may be activated by XO derived ROS. We assume that the activated NF-kappaB initiates transcription of target genes inducing cytokine production, which in turn disrupts the tight junctions leading to BT from the intestinal lumen to the MLNs and circulation.
Find related publications in this database (using NLM MeSH Indexing)
Analysis of Variance -
Animals -
Bacterial Translocation - immunology
Cholestasis - immunology Cholestasis - microbiology Cholestasis - physiopathology
Curcumin - pharmacology
Drugs, Chinese Herbal - pharmacology
Glutathione - drug effects
Ileum - drug effects Ileum - metabolism Ileum - pathology
Lipid Peroxidation -
Male -
Malondialdehyde - metabolism
NF-kappa B - antagonists & inhibitors NF-kappa B - metabolism
Neutrophil Activation -
Peroxidase - drug effects
Random Allocation -
Rats -
Rats, Sprague-Dawley -
Reactive Oxygen Species - metabolism
Signal Transduction -
Thalidomide - pharmacology
Xanthine Oxidase - metabolism

Find related publications in this database (Keywords)
xanthinoxidase
nuclear factor-kappa B
bacterial translocation
cholestasis
© Med Uni Graz Impressum